Dr Siamak Arami is a Consultant Haematologist at London North West University Healthcare trust since 2015 and an honorary senior clinical lecturer in haematology for Imperial College London, previously holding a post as a consultant haematologist in Kings College Hospital in London, developing a particular interest in leukaemia and myeloproliferative disorders. Dr Arami also pioneered the digital chemotherapy healthcare solution project in Kings College hospital and monitored the very first patient in UK with chemotherapy healthcare application on Apple technology.
Dr Arami qualified in Medicine in 2000, conducting immunology research at Royal Free Hospital, London in primary immunodeficiency syndromes in National Research Institute under World Health Organisation program. He specialised in haematology at the St Marys Hospital London and Northern deanery, receiving his membership of the Royal College of Physicians and the Royal College of Pathologists in 2008 and 2013, respectively. He completed his post-graduate fellowship in haematological cancers and stem cell transplantation at Fred Hutchinson Cancer Research Center and University of Washington in Seattle, USA.
Dr Arami’s research interests include digital health technology and management of patients with leukaemia and myeloproliferative disorders. He has been an investigator in a large number of practice-changing national and international trials with publications in international peer-reviewed journals . Dr Arami is the lead for myeloproliferative disorders and chronic myeloid leukaemia at London North West University Healthcare NHS trust. He is also the College tutor for Haematology training at London North West Healthcare NHS Trust.
As well as being a keen tennis player, Dr Arami enjoys travelling, organizing cancer charity events and spending time with his family.
MRCP Royal College of Physicians, UK 2008
FRCPath Royal College of Pathologists, UK 2013
Fellowship in haematological cancers Fred Hutchinson Cancer Research Centre, Seattle, USA 2014